These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 38545106)

  • 41. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9.
    Wang J; Shao Y; Bennett TA; Shankar RA; Wightman PD; Reddy LG
    J Biol Chem; 2006 Dec; 281(49):37427-34. PubMed ID: 17040905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Case report: hepatitis in a child infected with SARS-CoV-2 presenting toll-like receptor 7 Gln11Leu single nucleotide polymorphism.
    Pessoa NL; Bentes AA; de Carvalho AL; de Souza Silva TB; Alves PA; de Sousa Reis EV; Rodrigues TA; Kroon EG; Campos MA
    Virol J; 2021 Sep; 18(1):180. PubMed ID: 34482844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Toll-like receptor polymorphism in host immune response to infectious diseases: A review.
    Mukherjee S; Huda S; Sinha Babu SP
    Scand J Immunol; 2019 Jul; 90(1):e12771. PubMed ID: 31054156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
    Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 46. YAP/TEAD1 Complex Is a Default Repressor of Cardiac Toll-Like Receptor Genes.
    Gao Y; Sun Y; Ercan-Sencicek AG; King JS; Akerberg BN; Ma Q; Kontaridis MI; Pu WT; Lin Z
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of single and pairwise Toll-like receptor activation on neuroinflammation and neurodegeneration.
    Rosenberger K; Derkow K; Dembny P; Krüger C; Schott E; Lehnardt S
    J Neuroinflammation; 2014 Sep; 11():166. PubMed ID: 25239168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Toll-like receptors in the pathogenesis of COVID-19.
    Khanmohammadi S; Rezaei N
    J Med Virol; 2021 May; 93(5):2735-2739. PubMed ID: 33506952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
    O'Mahony DS; Pham U; Iyer R; Hawn TR; Liles WC
    Int J Med Sci; 2008 Jan; 5(1):1-8. PubMed ID: 18219369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toll-Like Receptors (TLRs) in Health and Disease: An Overview.
    Kumar V; Barrett JE
    Handb Exp Pharmacol; 2022; 276():1-21. PubMed ID: 35091824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracellular TLRs of Mast Cells in Innate and Acquired Immunity.
    Ogawa Y; Kinoshita M; Kawamura T; Shimada S
    Handb Exp Pharmacol; 2022; 276():133-159. PubMed ID: 34505203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.
    Olson JK; Miller SD
    J Immunol; 2004 Sep; 173(6):3916-24. PubMed ID: 15356140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.
    Lucifora J; Bonnin M; Aillot L; Fusil F; Maadadi S; Dimier L; Michelet M; Floriot O; Ollivier A; Rivoire M; Ait-Goughoulte M; Daffis S; Fletcher SP; Salvetti A; Cosset FL; Zoulim F; Durantel D
    Sci Rep; 2018 Mar; 8(1):5390. PubMed ID: 29599452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
    Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
    J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between Interleukin-21 and Interleukin-21 receptor gene polymorphisms with susceptibility to chronic hepatitis B virus infection and HBV spontaneous clearance in Iranian population.
    Shoraka S; Mohebbi SR; Hosseini SM; Hosseini Razavi A; Hatami Y; Sharifian A; Rostami-Nejad M; Asadzadeh Aghdaei H; Zali MR
    Microb Pathog; 2019 Mar; 128():263-267. PubMed ID: 30639626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of microRNA-155 correlates positively with the expression of Toll-like receptor 7 and modulates hepatitis B virus via C/EBP-β in hepatocytes.
    Sarkar N; Panigrahi R; Pal A; Biswas A; Singh SP; Kar SK; Bandopadhyay M; Das D; Saha D; Kanda T; Sugiyama M; Chakrabarti S; Banerjee A; Chakravarty R
    J Viral Hepat; 2015 Oct; 22(10):817-27. PubMed ID: 25720442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the innate immune signalling pathways in hepatocyte cell lines.
    Preiss S; Thompson A; Chen X; Rodgers S; Markovska V; Desmond P; Visvanathan K; Li K; Locarnini S; Revill P
    J Viral Hepat; 2008 Dec; 15(12):888-900. PubMed ID: 18673429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Toll-like receptors in immunity and inflammatory diseases: Past, present, and future.
    Vijay K
    Int Immunopharmacol; 2018 Jun; 59():391-412. PubMed ID: 29730580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro.
    Thompson AJ; Colledge D; Rodgers S; Wilson R; Revill P; Desmond P; Mansell A; Visvanathan K; Locarnini S
    Antivir Ther; 2009; 14(6):797-808. PubMed ID: 19812442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.